Thermo Fisher Scientific Launches New Extruder for Pharmaceutical Research
Thermo Fisher Scientific Inc., recently announced it launched the Thermo Scientific Pharma 11, a new version of its parallel co-rating twin-screw extruder designed specifically for pharmaceutical research. The 11-mm extruder is easy to use and designed to be fully scalable, minimize material costs and optimize laboratory space. To achieve this, the Pharma 11 extruder features a user-friendly touchscreen and simple washing options. The instrument’s screw and barrel designs are geometrically scalable, and the benchtop device uses a minimal amount of sample material (20 g).
“Our customers in pharmaceutical research are facing several challenges that the Pharma 11 extruder addresses head on,” said Karl Gerhard Hoppmann, Vice President and General Manager of Thermo Fisher’s material characterization business. “The instrument uses small quantities of sample material, solving for the limited availability of active ingredients in this research setting. The Pharma 11 extruder also offers a compact, robust design that saves space while at the same time providing full scalability with the entire line of Thermo Scientific compounding systems.”
The new Pharma 11 extruder offers easy cleaning and validation – all material contact parts are easily removable – as well as an intuitive touchscreen with integrated feeder control. The instrument features a throughput of 20 g/h to 2.5 kg/h and is easily convertible from hot melt extrusion (HME) to twin screw granulation (TSG) applications. The Pharma 11 extruder is ideal for a wide range of drug development applications, including drug delivery systems, implants, tablets, and granules. The GMP-compliant device is also suitable for clinical trials, and the compact design makes it ideal for glove box applications. The Pharma 11 extruder is available immediately. For more information, visit www.thermoscientific.com/mc.
Total Page Views: 1440
